Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 8
1982 21
1983 45
1984 64
1985 53
1986 70
1987 48
1988 47
1989 55
1990 71
1991 68
1992 64
1993 61
1994 59
1995 62
1996 61
1997 50
1998 52
1999 35
2000 35
2001 36
2002 44
2003 32
2004 36
2005 30
2006 34
2007 22
2008 24
2009 20
2010 16
2011 20
2012 15
2013 19
2014 17
2015 14
2016 17
2017 17
2018 13
2019 2
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

1,431 results
Results by year
Filters applied: . Clear all
Page 1
Collateral Damage: Insulin-Dependent Diabetes Induced With Checkpoint Inhibitors.
Stamatouli AM, Quandt Z, Perdigoto AL, Clark PL, Kluger H, Weiss SA, Gettinger S, Sznol M, Young A, Rushakoff R, Lee J, Bluestone JA, Anderson M, Herold KC. Stamatouli AM, et al. Diabetes. 2018 Aug;67(8):1471-1480. doi: 10.2337/dbi18-0002. Epub 2018 Jun 24. Diabetes. 2018. PMID: 29937434 Free PMC article. Review.
An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes.
Herold KC, Bundy BN, Long SA, Bluestone JA, DiMeglio LA, Dufort MJ, Gitelman SE, Gottlieb PA, Krischer JP, Linsley PS, Marks JB, Moore W, Moran A, Rodriguez H, Russell WE, Schatz D, Skyler JS, Tsalikian E, Wherrett DK, Ziegler AG, Greenbaum CJ; Type 1 Diabetes TrialNet Study Group. Herold KC, et al. N Engl J Med. 2019 Aug 15;381(7):603-613. doi: 10.1056/NEJMoa1902226. Epub 2019 Jun 9. N Engl J Med. 2019. PMID: 31180194 Free PMC article. Clinical Trial.
Genetics of Vitiligo.
Spritz RA, Andersen GH. Spritz RA, et al. Dermatol Clin. 2017 Apr;35(2):245-255. doi: 10.1016/j.det.2016.11.013. Dermatol Clin. 2017. PMID: 28317533 Free PMC article. Review.
Autoantibodies in type 1 diabetes.
Taplin CE, Barker JM. Taplin CE, et al. Autoimmunity. 2008 Feb;41(1):11-8. doi: 10.1080/08916930701619169. Autoimmunity. 2008. PMID: 18176860 Review.
1,431 results
Jump to page
Feedback